Cargando…

Live Birth Rate in Women with Recurrent Pregnancy Loss after In Vitro Fertilization with Concomitant Intravenous Immunoglobulin and Prednisone

Pregnancy loss after in vitro fertilization (IVF) is at least as common as after spontaneous conception. Recurrent pregnancy loss (RPL) may often have an immunological background, and it is therefore relevant to test immune-based interventions in these patients. The objective was to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Egerup, Pia, Nielsen, Henriette Svarre, Andersen, Anders Nyboe, Christiansen, Ole Bjarne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000183/ https://www.ncbi.nlm.nih.gov/pubmed/35407500 http://dx.doi.org/10.3390/jcm11071894

Ejemplares similares

The Effects of Intravenous Immunoglobulins in Women with Recurrent Miscarriages: A Systematic Review of Randomised Trials with Meta-Analyses and Trial Sequential Analyses Including Individual Patient Data
por: Egerup, Pia, et al.
Publicado: (2015)

The effects of immunotherapy with intravenous immunoglobulins versus no intervention, placebo, or usual care in patients with recurrent miscarriages: a protocol for a systematic review with meta-analyses, trial sequential analyses, and individual patient data meta-analyses of randomised clinical trials
por: Egerup, Pia, et al.
Publicado: (2014)

Pregnancy loss and risk of multiple sclerosis and autoimmune neurological disorder: A nationwide cohort study
por: Mikkelsen, Anders Pretzmann, et al.
Publicado: (2022)

Pregnancy Loss and the Risk of Myocardial Infarction, Stroke, and All‐Cause Mortality: A Nationwide Partner Comparison Cohort Study
por: Mikkelsen, Anders Pretzmann, et al.
Publicado: (2023)

Intravenous immunoglobulins may prevent prednisone-exacerbation in myasthenia gravis
por: Díez-Porras, Laura, et al.
Publicado: (2020)

Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss after assisted reproductive technology treatment: a protocol for a randomised, double-blind, placebo-controlled trial
por: Nørgaard-Pedersen, Caroline, et al.
Publicado: (2022)

The healthy female microbiome across body sites: effect of hormonal contraceptives and the menstrual cycle
por: Krog, Maria Christine, et al.
Publicado: (2022)

Effect of prednisone, aspirin, low molecular weight heparin and intravenous immunoglobulin on outcome of pregnancy in women with antiphospholipid syndrome
por: XIAO, JING, et al.
Publicado: (2013)

ESHRE guideline: recurrent pregnancy loss: an update in 2022(†)
por: Bender Atik, Ruth, et al.
Publicado: (2023)

Pregnancy Loss and Cancer Risk: A Nationwide Observational Study
por: Mikkelsen, Anders P., et al.
Publicado: (2019)

Observation on the clinical effect of high-dose Intravenous Immunoglobulin combined with low-dose prednisone acetate in the treatment of patients with Kawasaki Disease
por: Zhang, Hao, et al.
Publicado: (2021)

Comparison of a ‘freeze-all’ strategy including GnRH agonist trigger versus a ‘fresh transfer’ strategy including hCG trigger in assisted reproductive technology (ART): a study protocol for a randomised controlled trial
por: Stormlund, Sacha, et al.
Publicado: (2017)

Concomitant prednisone may alleviate methotrexate side-effects in rheumatoid arthritis patients
por: van der Leeuw, Matthijs S., et al.
Publicado: (2023)

Adherence Patterns for Abiraterone Acetate and Concomitant Prednisone Use in Patients with Prostate Cancer
por: Lafeuille, Marie-Hélène, et al.
Publicado: (2014)

A population-based survey on family intentions and fertility awareness in women and men in the United Kingdom and Denmark
por: Vassard, Ditte, et al.
Publicado: (2016)

Anxiety and depression in women with asthma prior to fertility treatment
por: Yifei Huang, Emilia, et al.
Publicado: (2023)

Phenome‐Wide Analysis of Short‐ and Long‐Run Disease Incidence Following Recurrent Pregnancy Loss Using Data From a 39‐Year Period
por: Westergaard, David, et al.
Publicado: (2020)

Special Issue Recurrent Pregnancy Loss: Etiology, Diagnosis, and Therapy
por: Christiansen, Ole Bjarne
Publicado: (2021)

Fear of childbirth predicts postpartum depression: a population-based analysis of 511 422 singleton births in Finland
por: Räisänen, Sari, et al.
Publicado: (2013)

Is there a Role of Intravenous Immunoglobulin in Immunologic Recurrent Pregnancy Loss?
por: Yang, Xiuhua, et al.
Publicado: (2020)

Effects of early maternal cancer and fertility treatment on the risk of adverse birth outcomes
por: Everhøj, Cathrine, et al.
Publicado: (2022)

Inheritance of the 8.1 ancestral haplotype in recurrent pregnancy loss
por: Kolte, Astrid M., et al.
Publicado: (2015)

Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses
por: Yamamoto, Haruko, et al.
Publicado: (2022)

Status one year after fertility assessment and counselling in women of reproductive age—a qualitative study
por: Sylvest, Randi, et al.
Publicado: (2018)

Timely care for extrauterine pregnancies during the COVID-19 pandemic is needed
por: la Cour Freiesleben, Nina, et al.
Publicado: (2021)

INTRAVENOUS IMMUNOGLOBULIN IN DERMATOLOGY
por: Dhar, Sandipan
Publicado: (2009)

Intravenous immunoglobulin treatment in a patient with adrenomyeloneuropathy
por: Jønch, Aia Elise, et al.
Publicado: (2012)

Mycophenolate-mofetil/prednisone: Recurrence of COVID-19: case report
Publicado: (2020)

In silico evidence for prednisone and progesterone efficacy in recurrent implantation failure treatment
por: Mahdian, Soodeh, et al.
Publicado: (2022)

Using Social Media for Qualitative Health Research in Danish Women of Reproductive Age: Online Focus Group Study on Facebook
por: Temmesen, Camilla Gry, et al.
Publicado: (2021)

Clinicopathologic and gastrointestinal effects of administration of prednisone, prednisone with omeprazole, or prednisone with probiotics to dogs: A double‐blind randomized trial
por: Rak, Mariola B., et al.
Publicado: (2023)

Women’s perceptions of fertility assessment and counselling 6 years after attending a Fertility Assessment and Counselling clinic in Denmark
por: Koert, E, et al.
Publicado: (2020)

Intravenous immunoglobulins improve live birth rate among women with underlying immune conditions and recurrent pregnancy loss: a systematic review and meta-analysis
por: Habets, Denise H. J., et al.
Publicado: (2022)

CLINICAL EXPERIENCE WITH INTRAVENOUS IMMUNOGLOBULIN AND TNF-A INHIBITOR THERAPIES FOR RECURRENT PREGNANCY LOSS
por: Sills, Eric Scott, et al.
Publicado: (2009)

Risk Factors and Predictive Models for Intravenous Immunoglobulin Resistance in Children with Recurrent Kawasaki Disease
por: Chen, Xi, et al.
Publicado: (2022)

Annexin A5 Promoter Haplotype M2 Is Not a Risk Factor for Recurrent Pregnancy Loss in Northern Europe
por: Nagirnaja, Liina, et al.
Publicado: (2015)

Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial
por: de Alarcon, Pedro A., et al.
Publicado: (2017)

Antibiotic-free vaginal microbiota transplant with donor engraftment, dysbiosis resolution and live birth after recurrent pregnancy loss: a proof of concept case study
por: Wrønding, Tine, et al.
Publicado: (2023)

Pro- and anti-inflammatory cytokines and growth factors in patients undergoing in vitro fertilization procedure treated with prednisone
por: Piekarska, Karolina, et al.
Publicado: (2023)

The impact of the Safe Delivery Application on knowledge and skills managing postpartum haemorrhage in a low resource setting: a cluster randomized controlled trial in West Wollega region, Ethiopia
por: Christiansen, Ann-Marie Hellerung, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_epusbtvknpkof8m0pfl2s9051t